New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
08:09 EDTWXWuXi PharmaTech, Pacific Biomarkers announce collaboration
WuXi PharmaTech and Pacific Biomarkers announced a biomarker collaboration. In a new agreement, PBI will provide access to its extensive menu of validated biomarker assays to support WuXi's integrated clinical trial testing services. This includes bioanalysis and central laboratory services for pharmaceutical and biotech companies performing clinical drug development in China. Biomarkers from PBI complement WuXi's own biomarker capabilities. PBI has a leading position in biomarkers for cardiovascular diseases, diabetes, obesity, acute kidney injury, musculoskeletal disorders, and inflammation. WuXi offers clinical biomarker services in anatomic pathology, hematology, genomics, and soluble biomarkers focusing on oncology and infectious diseases.
News For WX From The Last 14 Days
Check below for free stories on WX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
08:01 EDTWXWuXi PharmaTech passes FDA inspection for manufacture of API
Subscribe for More Information
August 13, 2014
16:43 EDTWXWuXi PharmaTech sees Q3 EPS 48c-50c, consensus 49c
Subscribe for More Information
16:41 EDTWXWuXi PharmaTech raises FY14 EPS view to $1.82-$1.86 from $1.80-$1.85
Subscribe for More Information
16:34 EDTWXWuXi PharmaTech reports Q2 EPS 49c, consensus 47c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use